| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/14/2013 | US20130302361 Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same |
| 11/14/2013 | US20130302360 Mucosal adjuvant composition |
| 11/14/2013 | US20130302356 Method of Treating Cancer with DLL4 Antagonist and Chemotherapeutic Agent |
| 11/14/2013 | US20130302352 Methods for the prevention and/or treatment of memory impairment |
| 11/14/2013 | US20130302351 Antagonism of the vip signaling pathway |
| 11/14/2013 | US20130302349 Novel ha binding agents |
| 11/14/2013 | US20130302345 Cd89 activation in therapy |
| 11/14/2013 | US20130302344 Methods and medicaments for the treatment of gout or pseudogout |
| 11/14/2013 | US20130302343 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease |
| 11/14/2013 | US20130302340 Human timp-1 antibodies |
| 11/14/2013 | US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt |
| 11/14/2013 | US20130302338 Dermatophagoid pteronyssinus (der p1) antigen epitope and anti-der p1 antibody |
| 11/14/2013 | US20130302333 Prevention and treatment of complement-associated eye conditions |
| 11/14/2013 | US20130302332 Method for treating inflammation |
| 11/14/2013 | US20130302330 Chimeric antigens for eliciting an immune response |
| 11/14/2013 | US20130302324 Methods for treating retinopathy with extended therapeutic effect |
| 11/14/2013 | US20130302323 Methods for treating diffuse large b-cell lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents |
| 11/14/2013 | US20130302322 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r) |
| 11/14/2013 | US20130302318 Anti-CD38 Antibody and Lenalidomide or Bortezomib for the Treatment of Multipe Myeloma and NHL |
| 11/14/2013 | US20130302317 Siglec-9 Binding Agents |
| 11/14/2013 | US20130302312 Method of treating a pathological syndrome and a pharmaceutical agent |
| 11/14/2013 | US20130302278 Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimens |
| 11/14/2013 | US20130302277 Method of treatment |
| 11/14/2013 | US20130302274 Combination therapy |
| 11/14/2013 | US20130302254 Antivenom |
| 11/13/2013 | EP2662441A1 Method for the in vitro maturation of dendritic cells |
| 11/13/2013 | EP2662386A1 Antibodies that bind to PLAC1 and block interaction between PLAC1 and FGF7 |
| 11/13/2013 | EP2662385A1 Method for improving physical properties of antibody |
| 11/13/2013 | EP2662092A1 Method for selecting patient to be given drug for treating septicemia |
| 11/13/2013 | EP2662091A2 Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases |
| 11/13/2013 | EP2662084A1 Mixture of non-digestible oligosaccharides for stimulating the immune system |
| 11/13/2013 | EP2662074A1 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals |
| 11/13/2013 | EP2661963A1 Method for diagnosing acute renal failure or chronic renal failure |
| 11/13/2013 | EP2661500A2 Clostridium difficile antigens |
| 11/13/2013 | EP2661450A1 Plasma kallikrein binding proteins |
| 11/13/2013 | EP2661448A2 Anti-il-12/il-23 antibodies and uses thereof |
| 11/13/2013 | EP2661442A1 Monomeric and multimeric immunogenic peptides |
| 11/13/2013 | EP2661440A2 Methods for preparation of glycosphingolipids and uses thereof |
| 11/13/2013 | EP2661282A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide |
| 11/13/2013 | EP2661279A2 Methods of treating age-related macular degeneration |
| 11/13/2013 | EP2661278A1 Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus |
| 11/13/2013 | EP2661277A2 A combination heptavalent vaccine |
| 11/13/2013 | EP2661276A1 Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositions |
| 11/13/2013 | EP2661253A1 Liposome formulation suitable for treating or preventing tuberculosis |
| 11/13/2013 | EP2374894A9 A method for producing influenza hemagglutinin multivalent vaccines |
| 11/13/2013 | CN103392001A Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same |
| 11/13/2013 | CN103391788A Inactivated poliovaccine |
| 11/13/2013 | CN103391784A Obesity-related genes and their proteins and uses thereof |
| 11/13/2013 | CN103387997A Pelodiscus sinensis picornavirus complete genome sequence and applications thereof |
| 11/13/2013 | CN103387996A Canine parvovirus-like particles and preparation method and application thereof |
| 11/13/2013 | CN103387615A Hand-foot-and-mouth disease vaccine based on HBc and EV71 VP4, and preparation method and application thereof |
| 11/13/2013 | CN103387605A RTN4B polypeptide and monoclonal antibody thereof, hybridoma cell strain generating monoclonal antibody, and preparation and application of RTN4B polypeptide, monoclonal antibody and hybridoma cell strain |
| 11/13/2013 | CN103387604A CD8+T cell epitope polypeptide of S1 protein of chicken IBV (Infectious Bronchitis Virus) S1 protein |
| 11/13/2013 | CN103386129A Flagellin as immunologic adjuvant for low-toxicity live vaccine LaSota strain of Newcastle disease and application of flagellin |
| 11/13/2013 | CN103386128A Tuberculosis subunit vaccine containing unite adjuvant |
| 11/13/2013 | CN103386127A Method for preparing vaccine by Newcastle disease virus cultured by using chick embryo continuous cell line and bioreactor |
| 11/13/2013 | CN103386126A Multivalent immunogenic composition containing enterovirus antigens |
| 11/13/2013 | CN103386125A Development of hemorrhagic fever with renal syndrome (HFRS) nasal mucosa immunization aerosol vaccine |
| 11/13/2013 | CN103386124A Multivalent recombinant protein subunit vaccine in chicken coccidiosis and application thereof |
| 11/13/2013 | CN103386123A Method and application of MEK used as costimulatory factor for preparing novel tumor vaccine |
| 11/13/2013 | CN103386119A Application of SIRT1 in adjusting rhythm and improving rhythm disorder |
| 11/13/2013 | CN103041386B Application of vibrio anguillarum recombinant protein |
| 11/13/2013 | CN102851249B Haemophilus parasuis LZ-20100109 strain and application thereof |
| 11/13/2013 | CN102649963B Human papillomavirus (HPV) L1-based recombinant adenovirus for preventing and treating esophagus cancer |
| 11/13/2013 | CN102552894B Preparation method for snakehead virulent ascitesosis disease vaccine |
| 11/13/2013 | CN102464726B Epimedium polysaccharide and components thereof as well as application thereof to vaccine adjuvant |
| 11/13/2013 | CN102281903B Method and formulation for reducing aggregation of a macromolecule under physiological conditions |
| 11/13/2013 | CN102281902B Method and formulation for reducing aggregation of a macromolecule under physiological conditions |
| 11/13/2013 | CN102159225B Non-typeable haemophilus influenzae vaccines and uses thereof |
| 11/13/2013 | CN102099057B A conjugate of an antibody against CD4 and antifusogenic peptides |
| 11/13/2013 | CN102070710B Specific GRA2a (Glycine Rich Antigen)-type antigenic protein of clonorchis sinensis and application thereof |
| 11/13/2013 | CN101981053B Pegylated Abeta FAB |
| 11/13/2013 | CN101687929B Monoclonal antibodies against claudin-18 for treatment of cancer |
| 11/13/2013 | CN101680897B Predicting response to a her dimerisation inhibitor based on low her3 expression |
| 11/13/2013 | CN101679516B Antigen-binding proteins targeting s. aureus ORF0657 |
| 11/13/2013 | CN101606062B Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 11/13/2013 | CN101605815B Method and arrangement for allowing enterprise and personal domains in the ims |
| 11/13/2013 | CN101443035B Vaccine for treatment or prophylaxis therapy of myasthenia gravis |
| 11/13/2013 | CN101389350B Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| 11/13/2013 | CN101151277B Anti-interferon gamma antibodies and methods of use thereof |
| 11/12/2013 | US8580939 Engineered Listeria and methods of use thereof |
| 11/12/2013 | US8580936 Polynucleotides encoding FGFR1-IIIc ECD fusion proteins |
| 11/12/2013 | US8580927 Engineered antibody constant domain molecules |
| 11/12/2013 | US8580745 Composition for therapeutic and cosmetic botulinum toxin |
| 11/12/2013 | US8580744 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 11/12/2013 | US8580730 Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists |
| 11/12/2013 | US8580492 Screening method for the identification of inhibitors of HIV Tat methylation by the lysine methyltransferase Set7/9 |
| 11/12/2013 | US8580490 Markers for screening anti-mycobacterial treatment efficacy |
| 11/12/2013 | US8580312 Radiation therapy agent |
| 11/12/2013 | US8580279 Compounds |
| 11/12/2013 | US8580278 Nutraceutical composition and methods for preventing or treating multiple sclerosis |
| 11/12/2013 | US8580277 Influenza hemagglutinin and neuraminidase variants |
| 11/12/2013 | US8580276 Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof |
| 11/12/2013 | US8580274 Drug transporter, and adjuvant and vaccine each utilizing same |
| 11/12/2013 | US8580273 TNF superfamily member light fusion proteins |
| 11/12/2013 | US8580272 Compositions and methods for detection of antibodies specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) |
| 11/12/2013 | US8580271 Detection kit containing a novel recombinant 15-kDA polypeptide useful for detecting human infection with Bartonella henselae |
| 11/12/2013 | US8580270 Respiratory synctial virus (RSV) sequences for protein expression and vaccines |
| 11/12/2013 | US8580268 CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity |
| 11/12/2013 | US8580267 Immunocytokines for tumour therapy with chemotherapeutic agents |